#pediatric cancer #CHOP #V Foundation

Significant Funding Announcement for Pediatric Cancer

In a groundbreaking announcement, the V Foundation for Cancer Research has allocated nearly $2 million in grants to the Children's Hospital of Philadelphia (CHOP). This funding aims to advance innovative research methods vital for improving pediatric cancer treatment and early detection, focusing especially on reducing disparities in cancer outcomes among children.

The Grant Recipients

Two eminent researchers at CHOP have received substantial grants as part of this initiative. Dr. Andrei Thomas-Tikhonenko, the Chief of the Division of Cancer Pathobiology, has been awarded a $1 million V Foundation Pediatric All-Star Cancer Research Grant. His research focuses on developing a novel chimeric antigen receptor (CAR) T-cell therapy specifically targeting T-cell acute lymphoblastic leukemia (T-ALL)—an aggressive blood cancer that predominantly affects children.

Dr. Thomas-Tikhonenko's project leverages insights from genetic and biological datasets along with laboratory studies. His primary goal is to explore P2RX5, a promising target found on leukemia cells. This research is not merely theoretical; it lays the groundwork for a potential first-in-human clinical trial, aiming to offer a more precise treatment option to children battling relapsed or treatment-resistant T-ALL. Notably, P2RX5-positive leukemias are disproportionately prevalent among African and Hispanic children, putting this research at the forefront of efforts to achieve equity in cancer treatment.

Following closely is Dr. Suzanne MacFarland, who has been awarded an $800,000 V Foundation Pediatric Translational Cancer Research Grant. Dr. MacFarland serves as an attending physician at CHOP’s Cancer Center and is the Director of its Cancer Predisposition Program. Her study focuses on utilizing a blood-based